CFC inhaler bill has support of House Commerce leadership in 1998, Rep. Kennedy says.
This article was originally published in The Tan Sheet
Executive Summary
CFC INHALER BILL SUPPORT FROM HOUSE COMMERCE LEADERSHIP is expected in 1998, Rep. Patrick Kennedy (D-R.I.) declared during Nov. 9 House floor discussion of the FDA reform bill. Attempts to include a provision in the bill to rescind FDA's advance notice of proposed rulemaking on chlorofluorocarbon-containing metered-dose inhalers failed in the current session, but Commerce Committee Chairman James Bliley (R-Va.) and Ranking Minority Member John Dingell (D-Mich.) have "agreed to a bill that will address this issue in the upcoming year," Kennedy said.